Log in to save to my catalogue

Homotherapy for heteropathy: therapeutic effect of Butein in NLRP3-driven diseases

Homotherapy for heteropathy: therapeutic effect of Butein in NLRP3-driven diseases

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1ba79f114826463d95517fc9e0bd24c4

Homotherapy for heteropathy: therapeutic effect of Butein in NLRP3-driven diseases

About this item

Full title

Homotherapy for heteropathy: therapeutic effect of Butein in NLRP3-driven diseases

Publisher

England: BioMed Central Ltd

Journal title

Cell communication and signaling, 2024-06, Vol.22 (1), p.315-16, Article 315

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Aberrant inflammatory responses drive the initiation and progression of various diseases, and hyperactivation of NLRP3 inflammasome is a key pathogenetic mechanism. Pharmacological inhibitors of NLRP3 represent a potential therapy for treating these diseases but are not yet clinically available. The natural product butein has excellent anti-inflamm...

Alternative Titles

Full title

Homotherapy for heteropathy: therapeutic effect of Butein in NLRP3-driven diseases

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1ba79f114826463d95517fc9e0bd24c4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1ba79f114826463d95517fc9e0bd24c4

Other Identifiers

ISSN

1478-811X

E-ISSN

1478-811X

DOI

10.1186/s12964-024-01695-7

How to access this item